Loading...
Ekso Bionics Holdings, Inc.
EKSO•NASDAQ
Healthcare
Medical - Instruments & Supplies
$4.82
$0.10(2.12%)
Ekso Bionics Holdings, Inc. (EKSO) Financial Performance & Income Statement Overview
Review Ekso Bionics Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-1.94%
↓ 1.94%
Operating Income Growth
30.78%
↑ 30.78%
Net Income Growth
25.45%
↑ 25.45%
Operating Cash Flow Growth
18.32%
↑ 18.32%
Operating Margin
-60.67%
↓ 60.67%
Gross Margin
53.39%
↑ 53.39%
Net Profit Margin
-61.51%
↓ 61.51%
ROE
-82.50%
↓ 82.50%
ROIC
-56.75%
↓ 56.75%
Ekso Bionics Holdings, Inc. (EKSO) Income Statement & Financial Overview
Review Ekso Bionics Holdings, Inc.'s (EKSO) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $5.09M | $4.13M | $4.95M | $3.76M |
| Cost of Revenue | $2.38M | $1.92M | $2.31M | $1.80M |
| Gross Profit | $2.71M | $2.21M | $2.64M | $1.95M |
| Gross Profit Ratio | $0.53 | $0.53 | $0.53 | $0.52 |
| R&D Expenses | $845000.00 | $777000.00 | $1.12M | $1.14M |
| SG&A Expenses | $4.10M | $4.07M | $3.86M | $4.07M |
| Operating Expenses | $4.94M | $4.85M | $4.97M | $5.21M |
| Total Costs & Expenses | $7.32M | $6.77M | $7.29M | $7.01M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $59000.00 | $79000.00 | $74000.00 | $57000.00 |
| Depreciation & Amortization | $398000.00 | $407000.00 | $397000.00 | $406000.00 |
| EBITDA | -$2.96M | -$1.59M | -$1.95M | -$2.97M |
| EBITDA Ratio | -$0.58 | -$0.38 | -$0.39 | -$0.79 |
| Operating Income | -$2.23M | -$2.64M | -$2.33M | -$3.26M |
| Operating Income Ratio | -$0.44 | -$0.64 | -$0.47 | -$0.87 |
| Other Income/Expenses (Net) | -$1.18M | $567000.00 | -$81000.00 | -$173000.00 |
| Income Before Tax | -$3.41M | -$2.07M | -$2.42M | -$3.43M |
| Income Before Tax Ratio | -$0.67 | -$0.50 | -$0.49 | -$0.91 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $362724.00 |
| Net Income | -$3.41M | -$2.07M | -$2.42M | -$3.43M |
| Net Income Ratio | -$0.67 | -$0.50 | -$0.49 | -$0.91 |
| EPS | -$0.17 | -$0.10 | -$0.13 | -$0.20 |
| Diluted EPS | -$0.17 | -$0.10 | -$0.13 | -$0.20 |
| Weighted Avg Shares Outstanding | $24.64M | $20.31M | $18.22M | $17.42M |
| Weighted Avg Shares Outstanding (Diluted) | $24.64M | $20.31M | $18.22M | $17.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan